(Q36689207)

15 August 2017

1 reference

title

Melatonin and sleep disorders associated with intellectual disability: a clinical review (English)

1 reference

disability affecting intellectual abilities

15 August 2017

0 references

intellectual disability

1 reference

based on heuristic

inferred from title

1 reference

Sajith SG

1

1 reference

15 August 2017

Clarke D

series ordinal

2

1 reference

15 August 2017

publication date

1 January 2007

1 reference

Journal of Intellectual Disability Research

15 August 2017

published in

1 reference

15 August 2017

volume

51

1 reference

15 August 2017

issue

Pt 1

1 reference

15 August 2017

page(s)

2-13

1 reference

Plasma concentrations of melatonin in man following oral absorption of different preparations

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Sleep problems and daytime challenging behaviour in a community-based sample of adults with intellectual disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Effects of exogenous melatonin on sleep: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Melatonin: a major regulator of the circadian rhythm of core temperature in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Melatonin triggers Crohn's disease symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Melatonin improves sleep in asthma: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Pharmacokinetics of melatonin in human sexual maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Melatonin for the Treatment of Sleep Disturbances in Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Psychological treatment of reported sleep disorder in adults with intellectual disability using a multiple baseline design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Sleep disorders and melatonin rhythms in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Increased bioavailability of oral melatonin after fluvoxamine coadministration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Does melatonin help people sleep?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Is melatonin associated with the development of autoimmune hepatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Melatonin for the treatment of handicapped children with severe sleep disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Aspects of melatonin manufacturing and requirements for a reliable active component

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Melatonin treatment of winter depression: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Increased nocturnal melatonin secretion in male patients with hypogonadotropic hypogonadism and delayed puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Serum melatonin kinetics and long-term melatonin treatment for sleep disorders in Rett syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Use of melatonin to treat sleep disorders in tuberous sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Effectiveness of melatonin in the treatment of sleep disturbances in children with Asperger disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Melatonin effect on seizures in children with severe neurologic deficit disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Melatonin treatment for sleep disorders in children with neurodevelopmental disorders: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Pro-convulsant effects of oral melatonin in neurologically disabled children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Elevated Melatonin Serum Concentrations in Psychiatric Patients Treated with Chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Immunomodulatory effects of melatonin in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Elevated serum melatonin is associated with the nocturnal worsening of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

The GABA(A) receptor mediates the hypnotic activity of melatonin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Melatonin is useful for recording sleep EEGs: a prospective audit of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Severe sleep disturbance and daytime challenging behaviour in children with severe learning disabilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Sleep-inducing effects of low doses of melatonin ingested in the evening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Effects of a low dose of melatonin on sleep in children with Angelman syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

Negative effects of melatonin on depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2788.2006.00893.X

10.1111/J.1365-2788.2006.00893.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference